Jeroncellvein , a specialized pharmaceutical manufacturing company, announced on the 28th that it was finally selected for the '2025 Baby Unicorn Development Project' hosted by the Ministry of SMEs and Startups.
The '2025 Baby Unicorn Development Project' is the first step of the global unicorn project, and is a project that discovers promising companies with innovative business models and proven growth potential that have the potential to grow into unicorn companies, and provides them with market development funds and special guarantees.
The Baby Unicorn Fostering Project is a fostering project that can be applied for by companies with a cumulative investment attraction performance of KRW 2 billion or more but less than KRW 10 billion or a corporate value of KRW 30 billion or more, and Jeroncellbein's excellent capabilities have been proven.
In particular, the selected companies will be provided with up to KRW 300 million in market development funds for new market research and exploration, and a special guarantee of up to KRW 5 billion. Through this selection, Jeroncellbein is expected to receive a wide range of support, including domestic and international investor relations (IR), venture capital (VC) investment linkage support, research and development (R&D) planning support, and global consulting.
Kim Deok-gyu, CEO of Jeroncellbein, said, “We will do our best to create continuous results through various programs supported by the Baby Unicorn Fostering Project,” and “We will expand the business area of PDRN, developed with our own patented technology, to meet market expectations.”
He continued, “Through this selection for the development project, we have once again proven our company’s growth potential,” and added, “We will make a leap forward as a representative global company with domestic and global expansion capabilities.”
- See more related articles
You must be logged in to post a comment.